fda ban on compounded tirzepatide The Impact of New Regulations The recent announcement that Tirzepatide

Oral routes are associated with delayed or inconsistent systemic effects, depending on molecular size, chemical modification, and formulation

The new drugs, a category called GLP-1 receptor agonists, are so effective, and already in such wide use, that they are beginning to broadly impact food and beverage sales

One of the most important is GLP-1 (glucagon-like peptide-1), which slows digestion, reduces appetite, and helps the pancreas release insulin

Date of Issuance: October 09, 2025 Location: Taizhou City, Jiangsu, China Product Type: Drug Products The warning letter for Taizhou Kangping highlights the specific risks associated with using spreadsheet software (Excel) for CGMP calculations without proper validation or security controls